XML 50 R4.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Revenues [Abstract]      
Net revenues $ 481,969 $ 453,911 $ 414,051
Operating costs:      
Salaries and related costs 274,233 259,228 237,067
Rent, supplies, contract labor and other 90,379 88,426 82,096
Provision for doubtful accounts 4,858 4,603 3,672
Closure costs 25 (9) 599
Total operating costs 369,495 352,248 323,434
Gross Profit 112,474 101,663 90,617
Corporate office costs 45,049 41,349 35,889
Operating income 67,425 60,314 54,728
Gain on sale of partnership interest 5,514 0 0
Gain on derecognition of debt 0 1,846 0
Interest and other income, net 46 93 88
Interest expense:      
Mandatorily redeemable non-controlling interests - change in redemption value 0 0 (12,894)
Mandatorily redeemable non-controlling interests - earnings allocable 0 0 (6,055)
Debt and other (2,079) (2,042) (2,111)
Total interest expense (2,079) (2,042) (21,060)
Income before taxes 70,906 60,211 33,756
Provision for income taxes 13,647 11,369 6,032
Net income 57,259 48,842 27,724
Less: net income attributable to non-controlling interests:      
Non-controlling interests - permanent equity (6,561) (5,536) (5,224)
Redeemable non-controlling interests - temporary equity (10,659) (8,433) (244)
Net income attributable to non-controlling interests (17,220) (13,969) (5,468)
Net income attributable to USPH shareholders $ 40,039 $ 34,873 $ 22,256
Basic and diluted earnings per share attributable to USPH shareholders (in dollars per share) $ 2.45 $ 1.31 $ 1.76
Shares used in computation - basic and diluted (in shares) 12,756 12,666 12,570
Dividends declared per common share (in dollars per share) $ 1.14 $ 0.92 $ 0.80
Net Patient Revenues [Member]      
Revenues [Abstract]      
Net revenues $ 433,345 $ 417,703 $ 389,226
Other Revenues [Member]      
Revenues [Abstract]      
Net revenues $ 48,624 $ 36,208 $ 24,825